Bleeding patterns during the menopausal transition in the multi-ethnic Study of Women's Health Across the Nation (SWAN): a prospective cohort study
- PMID: 24735184
- PMCID: PMC4199918
- DOI: 10.1111/1471-0528.12768
Bleeding patterns during the menopausal transition in the multi-ethnic Study of Women's Health Across the Nation (SWAN): a prospective cohort study
Abstract
Objective: Previous studies describing menses duration and heaviness of flow during the menopausal transition (MT) have been short in duration and limited to white women. We estimated the frequency of and risk factors for prolonged bleeding, spotting and heavy bleeding during the MT in an ethnically diverse population.
Design: Prospective community-based cohort study.
Setting usa: southeastern Michigan, northern California and Los Angeles, California.
Population: A total of 1320 midlife women who participated in the Study of Women's Health Across the Nation (SWAN) Menstrual Calendar Substudy. Participants included African-American, white, Chinese, and Japanese women.
Methods: Women completed daily menstrual calendars from 1996 to 2006, and provided information on hormone therapy, smoking and physical activity. Annual measures included height and weight. Kaplan-Meier survival analysis and multivariable regression were used to analyse the data.
Main outcome measures: Menses of 10+ days, spotting of 6+ days, heavy bleeding of 3+ days.
Results: At least three occurrences of menses 10+ days was reported by 77.7% (95% confidence interval [95% CI] 56.7-93.2), of 6+ days of spotting by 66.8% (95% CI 55.2-78.0) and of 3+ days of heavy bleeding by 34.5% (95% CI 30.2-39.2) of women. Menses of 10+ days, 6+ days of spotting, and 3+ days of heavy bleeding were associated with MT stage, uterine fibroids, hormone use and ethnicity. Body mass index was associated with 3+ days of heavy bleeding.
Conclusions: These data provide clinicians and women with important information about the expected frequency of prolonged and heavy bleeding and spotting during the menopausal transition that may facilitate clinical decision making.
Keywords: Abnormal uterine bleeding; menopausal transition; menopause; menstruation.
© 2014 Royal College of Obstetricians and Gynaecologists.
Conflict of interest statement
The authors report no conflict of interest.
The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (NIH), National Institute on Aging (NIA), the National Institute of Nursing Research (NINR) and the NIH Office of Research on Women’s Health (ORWH).
Comment in
-
Menstrual bleeding experiences are as important as expectations.BJOG. 2014 Nov;121(12):1573. doi: 10.1111/1471-0528.12771. BJOG. 2014. PMID: 25348442 No abstract available.
Similar articles
-
Influence of race/ethnicity, body mass index, and proximity of menopause on menstrual cycle patterns in the menopausal transition: the Study of Women's Health Across the Nation.Menopause. 2015 Feb;22(2):159-65. doi: 10.1097/GME.0000000000000293. Menopause. 2015. PMID: 25026113 Free PMC article.
-
Duration of the menopausal transition is longer in women with young age at onset: the multiethnic Study of Women's Health Across the Nation.Menopause. 2017 Feb;24(2):142-149. doi: 10.1097/GME.0000000000000736. Menopause. 2017. PMID: 27676632 Free PMC article.
-
Classifying menopause stage by menstrual calendars and annual interviews: need for improved questionnaires.Menopause. 2013 Jul;20(7):727-35. doi: 10.1097/GME.0b013e3182825ff2. Menopause. 2013. PMID: 23481122 Free PMC article.
-
The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN).Menopause. 2019 Oct;26(10):1213-1227. doi: 10.1097/GME.0000000000001424. Menopause. 2019. PMID: 31568098 Free PMC article. Review.
-
Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52 mg) during the first-year after insertion: a systematic review and meta-analysis.Am J Obstet Gynecol. 2020 May;222(5):451-468.e9. doi: 10.1016/j.ajog.2019.09.044. Epub 2019 Oct 4. Am J Obstet Gynecol. 2020. PMID: 31589865 Review.
Cited by
-
Rates of medical or surgical treatment for women with heavy menstrual bleeding: the ECLIPSE trial 10-year observational follow-up study.Health Technol Assess. 2023 Oct;27(17):1-50. doi: 10.3310/JHSW0174. Health Technol Assess. 2023. PMID: 37924269 Free PMC article.
-
Abnormal uterine bleeding patterns determined through menstrual tracking among participants in the Apple Women's Health Study.Am J Obstet Gynecol. 2023 Feb;228(2):213.e1-213.e22. doi: 10.1016/j.ajog.2022.10.029. Epub 2022 Oct 29. Am J Obstet Gynecol. 2023. PMID: 36414993 Free PMC article.
-
Abnormal Uterine Bleeding in Perimenopausal Women: The Role of Hysteroscopy and Its Impact on Quality of Life and Sexuality.Diagnostics (Basel). 2022 May 9;12(5):1176. doi: 10.3390/diagnostics12051176. Diagnostics (Basel). 2022. PMID: 35626331 Free PMC article. Review.
-
Impact of prior preterm or term small for gestational age birth on maternal blood pressure during the menopause transition in the Study of Women's Health Across the Nation.Menopause. 2021 Feb 8;28(3):255-262. doi: 10.1097/GME.0000000000001739. Menopause. 2021. PMID: 33570873 Free PMC article.
-
Comparison between Different Diagnostic Strategies in Low-Risk Reproductive Age and Pre-Menopausal Women Presenting Abnormal Uterine Bleeding.Diagnostics (Basel). 2020 Oct 30;10(11):884. doi: 10.3390/diagnostics10110884. Diagnostics (Basel). 2020. PMID: 33142970 Free PMC article.
References
-
- Whiteman MK, Kuklina E, Jamieson DJ, Hillis SD, Marchbanks PA. Inpatient hospitalization for gynecologic disorders in the United States. Am J Obstet Gynecol. 2010 Jun;202(6):541 e1–6. - PubMed
-
- Liu Z, Doan QV, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health. 2007 May-Jun;10(3):183–94. - PubMed
-
- Fraser IS, Critchley HO, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011 Sep;29(5):383–90. - PubMed
-
- Munro MG, Critchley HO, Broder MS, Fraser IS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011 Apr;113(1):3–13. - PubMed
-
- Munro MG, Critchley HO, Fraser IS. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril. 2011 Jun;95(7):2204–8. 8 e1–3. - PubMed
Publication types
MeSH terms
Grants and funding
- U01AG012535/AG/NIA NIH HHS/United States
- U01 AG012554/AG/NIA NIH HHS/United States
- U01AG012546/AG/NIA NIH HHS/United States
- R24 HD041028/HD/NICHD NIH HHS/United States
- U01AG012495/AG/NIA NIH HHS/United States
- U01AG012531/AG/NIA NIH HHS/United States
- U01AG012505/AG/NIA NIH HHS/United States
- U01AG012539/AG/NIA NIH HHS/United States
- U01 AG012495/AG/NIA NIH HHS/United States
- U01 AG012505/AG/NIA NIH HHS/United States
- U01 AG012531/AG/NIA NIH HHS/United States
- R01 AG021543/AG/NIA NIH HHS/United States
- U01NR004061/NR/NINR NIH HHS/United States
- U01AG012553/AG/NIA NIH HHS/United States
- U01 AG012535/AG/NIA NIH HHS/United States
- U01 AG012553/AG/NIA NIH HHS/United States
- U01 NR004061/NR/NINR NIH HHS/United States
- U01 AG012539/AG/NIA NIH HHS/United States
- U01AG012554/AG/NIA NIH HHS/United States
- U01 AG012546/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
